Urra JM - Search Results

1

TaqI polymorphism in the complement component C7 gene.

Coto E, Martinez-Naves E, Dominguez O, Urra JM, Rodriguez V, López-Larrea C. Coto E, et al. Among authors: urra jm. Nucleic Acids Res. 1990 Apr 11;18(7):1929. doi: 10.1093/nar/18.7.1929-a. Nucleic Acids Res. 1990. PMID: 1970871 Free PMC article.

2

DNA polymorphisms and linkage relationship of the human complement component C6, C7, and C9 genes.

Coto E, Martínez-Naves E, Domínguez O, DiScipio RG, Urra JM, López-Larrea C. Coto E, et al. Among authors: urra jm. Immunogenetics. 1991;33(3):184-7. doi: 10.1007/BF01719238. Immunogenetics. 1991. PMID: 1672663

3

SacI polymorphism at the human TCR delta chain constant region (TCRD).

Martínez-Naves E, Coto E, Urra JM, Setién F, Lopez-Larrea C. Martínez-Naves E, et al. Among authors: urra jm. Nucleic Acids Res. 1991 Feb 11;19(3):685. doi: 10.1093/nar/19.3.685. Nucleic Acids Res. 1991. PMID: 1672760 Free PMC article.

4

TaqI polymorphism at the human complement component C9 gene.

Coto E, Domínguez O, Martínez-Naves E, Urra JM, Gutiérrez V, López-Larrea C. Coto E, et al. Among authors: urra jm. Nucleic Acids Res. 1990 Sep 25;18(18):5581. doi: 10.1093/nar/18.18.5581. Nucleic Acids Res. 1990. PMID: 1977126 Free PMC article.

5

Germline repertoire of T-cell receptor beta-chain genes in patients with insulin-dependent diabetes mellitus.

Martínez-Naves E, Coto E, Gutiérrez V, Urra JM, Setién F, Domínguez O, Hood LE, López-Larrea C. Martínez-Naves E, et al. Among authors: urra jm. Hum Immunol. 1991 Jun;31(2):77-80. doi: 10.1016/0198-8859(91)90008-w. Hum Immunol. 1991. PMID: 1676706

6

DNA analysis of HLA-DR4B1 subtypes in multiple sclerosis by specific oligonucleotide probes.

Victoria-Gutierrez M, Martinez-Naves E, Coto E, Dominguez O, Uría F, Urra JM, López-Larrea C. Victoria-Gutierrez M, et al. Among authors: urra jm. J Neuroimmunol. 1991 Jun;32(3):279-83. doi: 10.1016/0165-5728(91)90198-g. J Neuroimmunol. 1991. PMID: 2033119

7

Tumor necrosis factor alpha is released by monocytes in OKT3 monoclonal antibody immunosuppressive therapy.

Urra JM, Peces R, Martinez-Naves E, Gutierrez V, Setién F, López-Larrea C. Urra JM, et al. Transplant Proc. 1992 Dec;24(6):2542-4. Transplant Proc. 1992. PMID: 1465859 No abstract available.

8

Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.

Peces R, Urra JM, Gorostidi M, López-Larrea C. Peces R, et al. Among authors: urra jm. Transplant Proc. 1992 Dec;24(6):2596-9. Transplant Proc. 1992. PMID: 1465877 No abstract available.

9

High-dose methylprednisolone inhibits the OKT3-induced cytokine-related syndrome.

Peces R, Urra JM, Escalada P, Gorostidi M, González E, López-Larrea C. Peces R, et al. Among authors: urra jm. Nephron. 1993;63(1):118. doi: 10.1159/000187159. Nephron. 1993. PMID: 8446242 Free article. No abstract available.

10

Effect of calcium-channel blocker on tumour necrosis factor alpha (TNF alpha) production in cyclosporin-treated renal transplant recipients.

Peces R, Urra JM. Peces R, et al. Among authors: urra jm. Nephrol Dial Transplant. 1995;10(6):871-3. Nephrol Dial Transplant. 1995. PMID: 7566619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters